Filbrandt Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Filbrandt Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$16K	Hold	101	–	–	0.01%	121
2021 Q2	$16K	Hold	101	–	–	0.01%	120
2021 Q1	$15K	Sell	101 -70	-41%	-$11.1K	0.01%	119
2020 Q4	$26K	Buy	+171	New	+$24.4K	0.02%	110
2020 Q3	–	Sell	-200	Closed	-$27K	–	244
2020 Q2	$27K	Buy	+200	New	+$25.5K	0.02%	174

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Filbrandt Wealth Management's IBB Position: Q3 2021 in Review

Filbrandt Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2021 at 101 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #121.

Filbrandt Wealth Management first reported a position in IBB in Q2 2020 and has held it in 5 quarters since. The position peaked at $27K in Q2 2020. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Filbrandt Wealth Management held 101 shares of iShares Biotechnology ETF worth $16K as of Q3 2021.
Filbrandt Wealth Management left its iShares Biotechnology ETF share count unchanged in Q3 2021.
iShares Biotechnology ETF made up 0.01% of Filbrandt Wealth Management's portfolio in Q3 2021, its #121 holding.
Filbrandt Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 5 quarters since.
Filbrandt Wealth Management's iShares Biotechnology ETF position peaked at $27K in Q2 2020.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.